Current NDC auxiliary source row compounder:2401

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 73198-073
Product Ndc: 73198-073
Product Ndc Digits: 73198073
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Preserved Acetylcysteine
Proprietary Name Suffix: [empty]
Nonproprietary Name: Acetylcysteine 200 mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Olympia Pharmacy
Establishment Name: Olympia Pharmacy
Establishment Fei: [empty]
Substance Name: ACETYLCYSTEINE
Active Ingredients Info: 200 mg/1 mL
History Active Ingredients Raw: ACETYLCYSTEINE
History Active Ingredients Info Raw: 200 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 73198-073-30
Package Ndc: 73198-073-30
Package Ndc Digits: 7319807330
Package Ndc11: 73198007330
Package Description: 30 mL in 1 VIAL, MULTI-DOSE (73198-073-30)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:2401
Source Row Number: 2401
Source Row Hash: dc2ab33dc56f5e1332e09066ccfaaa741a47319fbed97f61c916f9d0b968ea9d
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAVENOUS",
    "PRODUCTNDC": "73198-073",
    "DEASCHEDULE": "",
    "LABELERNAME": "Olympia Pharmacy",
    "SUBSTANCENAME": "ACETYLCYSTEINE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "73198-073-30",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Preserved Acetylcysteine",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Acetylcysteine 200 mg/mL",
    "PACKAGEDESCRIPTION": "30 mL in 1 VIAL, MULTI-DOSE (73198-073-30) ",
    "ACTIVEINGREDIENTSINFO": "200 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:2401
Source Row Number: 2401
Status Scope: package
Lookup Ndc: 73198-073-30
Lookup Ndc Digits: 7319807330
Product Ndc: 73198-073
Product Ndc Digits: 73198073
Package Ndc: 73198-073-30
Package Ndc Digits: 7319807330
Package Ndc11: 73198007330
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: dc2ab33dc56f5e1332e09066ccfaaa741a47319fbed97f61c916f9d0b968ea9d
Import Run Id: 20261024T140201Z
Loaded At: 2026-10-24 14:07:01